Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Warning Signs in Young-Onset CRC Data; Rifaximin Drift in Cirrhosis; Neonatal Hep C

Warning Signs in Young-Onset CRC Data; Rifaximin Drift in Cirrhosis; Neonatal Hep C
ShareXFacebook

(MedPage Today) -- Among French patients under 40 with early-onset colorectal cancer (CRC), the incidence of multiple-site metastases increased by 10% annually from 2004 to 2021, and no survival gains were observed for those with peritoneal involvement...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

First Gene Therapy Approved for Hearing Loss
MedPage Today

First Gene Therapy Approved for Hearing Loss

(MedPage Today) -- The FDA granted accelerated approval to lunsotogene parvec (Otarmeni) as the first gene therapy for genetic hearing loss, the agency announced on Thursday. An adeno-associated virus vector-based gene therapy, lunsotogene parvec...

Read more →
Advertisement